These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31167247)

  • 41. Outpatient Management of Patients with Immune Thrombocytopenia (ITP) by Hematologists 1995-2014.
    Weide R; Feiten S; Friesenhahn V; Heymanns J; Kleboth K; Thomalla J; van Roye C; Köppler H
    Oncol Res Treat; 2016; 39(1-2):41-4. PubMed ID: 26891217
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Epidemiology and pharmacoepidemiology of immune thrombocytopenia].
    Moulis G; Lapeyre-Mestre M; Adoue D; Sailler L
    Rev Med Interne; 2017 Jul; 38(7):444-449. PubMed ID: 28131440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients.
    Lozano ML; Mingot-Castellano ME; Perera MM; Jarque I; Campos-Alvarez RM; González-López TJ; Carreño-Tarragona G; Bermejo N; Lopez-Fernandez MF; de Andrés A; Valcarcel D; Casado-Montero LF; Alvarez-Roman MT; Orts MI; Novelli S; González-Porras JR; Bolaños E; López-Ansoar E; Orna-Montero E; Vicente V
    Blood Cells Mol Dis; 2021 Feb; 86():102505. PubMed ID: 32979651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of splenectomy for immune thrombocytopenic purpura (ITP) in the era of new second-line therapies and in the setting of a high prevalence of HIV-associated ITP.
    Antel KR; Panieri E; Novitzky N
    S Afr Med J; 2015 Apr; 105(5):408-12. PubMed ID: 26242673
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immune thrombocytopenia--pathophysiology and treatment].
    Ghanima W; Holme PA; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2010 Nov; 130(21):2120-3. PubMed ID: 21052113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Need for an improved vaccination rate in primary immune thrombocytopenia patients exposed to rituximab or splenectomy. A nationwide population-based study in France.
    Moulis G; Lapeyre-Mestre M; Mahévas M; Montastruc JL; Sailler L
    Am J Hematol; 2015 Apr; 90(4):301-5. PubMed ID: 25557586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Children with Persistent and Chronic Idiopathic Thrombocytopenic Purpura: 4 Infusions of Rituximab and Three 4-Day Cycles of Dexamethasone.
    Oved JH; Lee CSY; Bussel JB
    J Pediatr; 2017 Dec; 191():225-231. PubMed ID: 29173312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP.
    Rodeghiero F
    Br J Haematol; 2018 Apr; 181(2):183-195. PubMed ID: 29479668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of pediatric primary immune thrombocytopenia with thrombopoietin receptor agonists.
    Kühne T
    Semin Hematol; 2015 Jan; 52(1):25-30. PubMed ID: 25578416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics.
    Journeycake JM
    Hematology Am Soc Hematol Educ Program; 2012; 2012():444-9. PubMed ID: 23233617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current Management of Primary Immune Thrombocytopenia.
    Provan D; Newland AC
    Adv Ther; 2015 Oct; 32(10):875-87. PubMed ID: 26499177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reemergence of Splenectomy for ITP Second-line Treatment?
    Chater C; Terriou L; Duhamel A; Launay D; Chambon JP; Pruvot FR; Rogosnitzky M; Zerbib P
    Ann Surg; 2016 Nov; 264(5):772-777. PubMed ID: 27741009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term outcomes of patients treated with rituximab as second-line treatment for adult immune thrombocytopenia - Follow-up of the RITP study.
    Tjønnfjord E; Holme PA; Darne B; Khelif A; Waage A; Michel M; Ben Romdhan N; Ghanima W
    Br J Haematol; 2020 Nov; 191(3):460-465. PubMed ID: 32342497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Refractory immune thrombocytopenic purpura: current strategies for investigation and management.
    Psaila B; Bussel JB
    Br J Haematol; 2008 Oct; 143(1):16-26. PubMed ID: 18573111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immune thrombocytopenias: pathophysiology and treatment].
    Godeau B
    Bull Acad Natl Med; 2013 Feb; 197(2):407-17. PubMed ID: 24919370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study.
    Mahévas M; Fain O; Ebbo M; Roudot-Thoraval F; Limal N; Khellaf M; Schleinitz N; Bierling P; Languille L; Godeau B; Michel M
    Br J Haematol; 2014 Jun; 165(6):865-9. PubMed ID: 24725224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Understanding how older age drives decision-making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients.
    Palandri F; Catani L; Auteri G; Bartoletti D; Fatica S; Fusco A; Bacchi Reggiani ML; Cavo M; Vianelli N
    Br J Haematol; 2019 Feb; 184(3):424-430. PubMed ID: 30408157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transitioning patients with immune thrombocytopenia to second-line therapy: Challenges and best practices.
    Cuker A
    Am J Hematol; 2018 Jun; 93(6):816-823. PubMed ID: 29574922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quality of life is an important indication for second-line treatment in children with immune thrombocytopenia.
    Shimano KA; Neunert C; Bussel JB; Klaassen RJ; Bhat R; Pastore YD; Lambert MP; Bennett CM; Despotovic JM; Forbes P; Grace RF
    Pediatr Blood Cancer; 2021 Jun; 68(6):e29023. PubMed ID: 33764667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.